Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
The adaptive immune system plays an important role in the development and progression of atherosclerotic cardiovascular disease. B cells can have both proatherogenic and atheroprotective roles, making treatments aimed at modulating B cells important therapeutic targets. The innate-like B-cell response is generally considered atheroprotective, while the adaptive response is associated with mixed consequences for atherosclerosis. Additionally, interactions of B cells with components of the adaptive and innate immune system, including T cells and complement, also represent key points for therapeutic regulation. In this review, we discuss therapeutic approaches based on B-cell depletion, modulation of B-cell survival, manipulation of both the antibody-dependent and antibody-independent B-cell response, and emerging immunization techniques.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1524-4636
Volume Title
Publisher
Publisher DOI
Sponsorship
British Heart Foundation (PG/23/11508)
Heart Research UK (RG2699/21/23)
Leducq Foundation For Cardiovascular Research (20CVD03)